These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1783455)

  • 1. Improved on-line thoracic duct drainage for lymphocytapheresis.
    Sato T; Koga N; Nagano T; Ohteki H; Masuda T; Agishi T
    Int J Artif Organs; 1991 Dec; 14(12):800-4. PubMed ID: 1783455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocytapheresis and lymphosorption as the methods of pathogenetic therapy of nonspecific ulcerative colitis].
    Ganichkin AM; Iaitskiĭ NA; Dudka VV; Vasil'ev SV; Grigorian VV; Aĭvazian IA
    Vestn Khir Im I I Grek; 1991 Jan; 146(1):28-31. PubMed ID: 1650992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracic duct drainage in rheumatoid arthritis.
    Vaughan JH; Fox RI; Abresch RJ; Tsoukas CD; Curd JG; Carson DA
    Clin Exp Immunol; 1984 Dec; 58(3):645-53. PubMed ID: 6334581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis.
    Ueo T; Tanaka S; Tominaga Y; Ogawa H; Sakurami T
    Arthritis Rheum; 1979 Dec; 22(12):1405-12. PubMed ID: 518724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal irradiation of thoracic duct lymph as immunosuppressive treatment in rheumatoid arthritis.
    Edgren J; Klockars M; Weber T; Wangel A; Linström B; Stenstrand K; Pettersson T; Riska H; Kajander A; Wegelius O
    Scand J Rheumatol; 1976; 5(2):108-12. PubMed ID: 1084574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell separating property and clinical effect of lymphocytapheresis with leukocyte removal filter.
    Akizawa T; Kinugasa E; Koshikawa S; Nishimura T; Kuroda H
    Prog Clin Biol Res; 1990; 337():23-5. PubMed ID: 2352982
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis.
    Kondoh T; Hidaka Y; Katoh H; Inoue N; Saito S
    Artif Organs; 1991 Jun; 15(3):180-8. PubMed ID: 1867528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apheresis and rheumatoid arthritis.
    Decker JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):666-7. PubMed ID: 6846981
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage.
    Machleder HI; Paulus H
    Surgery; 1978 Jul; 84(1):157-65. PubMed ID: 307281
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of repeated leukapheresis in patients with severe refractory rheumatoid arthritis.
    Wilder RL; Yarboro CH; Decker JL
    Prog Clin Biol Res; 1982; 106():49-59. PubMed ID: 6757953
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocytapheresis in the treatment of rheumatoid arthritis: clinical and immunological studies.
    Indiveri F; Rogna S; Viglione D; Pierri I; Scudeletti M; Grifoni V
    Int J Artif Organs; 1985 May; 8(3):147-54. PubMed ID: 3875567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extracorporeal immunotherapy in rheumatoid polyarthritis].
    Boloşiu HD; Duţu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(5):393-400. PubMed ID: 6113657
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficient harvest of in vivo IL-2-activated CD3+ lymphocytes for adoptive immunotherapy by selective leukapheresis (lymphocytapheresis).
    Masucci G; Svensson A; Hansson M; Hansson J; Nakazawa T; Salazar F; Petersson M; Kiessling R
    J Hematother; 1997 Jun; 6(3):253-60. PubMed ID: 9234180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph.
    Fox RI; Fong S; Tsoukas C; Vaughan JH
    J Immunol; 1984 Jun; 132(6):2883-7. PubMed ID: 6609962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-lymphotropic virus type I associated myelopathy treated effectively with lymphocytapheresis using a leukocyte removal filter.
    Oishi M; Mochizuki Y; Hara M; Uryu H; Osaka S; Maejima M; Sawada S; Takasu T
    Intern Med; 1995 Dec; 34(12):1215-9. PubMed ID: 8929654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic duct fistula and renal transplantation.
    Starzl TE; Weil R; Koep LJ; McCalmon RT; Terasaki PI; Iwaki Y; Schröter GP; Franks JJ; Subryan V; Halgrimson CG
    Ann Surg; 1979 Oct; 190(4):474-86. PubMed ID: 384943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytapheresis--a feasible treatment for rheumatoid arthritis.
    Emery P; Smith GN; Panayi GS
    Br J Rheumatol; 1986 Feb; 25(1):40-3. PubMed ID: 3942846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocytapheresis in rheumatoid arthritis.
    Hidaka T; Hashiba Y; Kubo K; Kai Y; Maeda K
    Transfus Apher Sci; 2017 Oct; 56(5):698-702. PubMed ID: 28918917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drainage of thoracic lymph duct in the treatment of patients with rheumatoid arthritis].
    Siniachenko VV; Siniachenko OV; Kvasha VI; Diadyk AI; Kharaberiush VA
    Ter Arkh; 1982; 54(9):96-9. PubMed ID: 7179164
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of multiple sclerosis with lymphocytapheresis using a leukocyte adsorption column].
    Sato T; Imamura N; Nozaki K; Ishigaki Y
    Nihon Rinsho; 1994 Nov; 52(11):3032-7. PubMed ID: 7996706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.